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2913A Genetically Vulnerable
Myocardium May
Predispose to MyocarditisDeath from myocarditis requires the presence of
myocardial inﬂammation, without any other struc-
tural heart disease, and is frequently associated with
a viral infection (1). We postulate that genetic defects
in structural proteins cause the myocardium to
become vulnerable and predisposed to myocardial
inﬂammation by a pathogenic agent. To prove this
hypothesis, we prospectively collected 3 cases of
myocarditis-related sudden death (SD), according to
the Dallas criteria (2). To further investigate the
genetic basis, we screened the most prevalent 55
sudden cardiac death–related genes (3). Family
members were clinically and genetically investigated.
The local ethics committee approved the study.
Family 1 (Figure 1). This was a 10-year-old healthy
boy (III.1) who was experiencing canker sores,
transmitted from his brother. Genetic analysis
revealed 3 novel potentially pathogenic genetic
variants (PPGV): p.R413X_PKP2, associated with
arrhythmogenic right ventricular cardiomyopathy
(CM060431), and 2 missense PPGV (p.L1591Q_MYH7,
and p.A20252P_TTN). All were predicted as disease-
causing in silico. His uncle died at age 15 years of
unexplained SD (II.3), without autopsy. Three
asymptomatic members had inherited the 3 variants
and had abnormal CMR: the mother’s CMR (II.2) had
areas of right ventricular aneurisms, dyskinesia, and
patches of interstitial ﬁbrosis; the youngest uncle’s
CMR (II.6) had biventricular dilation, with no ﬁbrosis
or fatty inﬁltration; and the grandmother’s CMR (I.1)
had areas of RV dyskinesia and aneurysms with
patchy ﬁbrosis. An uncle (II.5) inherited the MHY7
variant and had a normal electrocardiogram and
exercise test. The 2 brothers (III.2 and III.3) had a
normal echocardiogram. Individual III.2 had
inherited the variation in PKP2. Individual III.3 had
inherited the other 2 PPGV. We considered the
nonsense variation in PKP2 the culprit of the disease,
whereas the additional variants could be modulators
of the phenotype.
Family 2 (Figure 1). Thiswas a 15-year-old boywhowas
experiencing low-grade fever, present in individuals in
his school class. Genetic analysis revealed 4 missense
variants. The variant DSP_p.E290K, rs397816974, not
identiﬁed in global databases, was predicted in silico as
deleterious. The variant PKP2_p.Q62K, rs199601548,
present in very low frequency, was classiﬁed as of
unknown signiﬁcance. Other 2 genetic variants werepredicted in silico as benign (JPH2_p.A181T) and
deleterious (TTN_p.S30475G). His sister’s CMR (III.2)
showed wide ﬁbrotic areas in the left ventricular
myocardium. She carried DSP (p.E290K) and TTN
(p.S30475G). The mother’s CMR (II.2) showed ﬁbrotic
interstitial areas in the left ventricle. She carried DSP
(p.E290K) and JPH2 (p.A181T). His father (II.1) had
normal CMR and carried PKP2 (p.Q62K) and TTN
(p.S30475G). Thus, the only segregating pathogenic
variant was DSP (p.E290K). The grandfather (I.1) died
suddenly at a young age without autopsy.
Family 3 (Figure 1). He was a healthy 40-year-old
physician (III.1). During the previous days, he had
been experiencing low-grade night fevers. Genetic
analysis revealed a rare novel variant in DSC2
(p.T305del), predicted in silico as deleterious.
Family genetic screening identiﬁed the same variant
in his mother (II.2) and his brother (III.4), as well as
1 of his children (IV.2) and a nephew (IV.4). All were
asymptomatic and had normal clinical tests. This
variant was classiﬁed as of uncertain signiﬁcance
due to the lack of segregation.
We compared the prevalence of these genetic var-
iants in 100 cases of unexplained SD. We identiﬁed
rare desmosomal variants in 14.7% of the population,
much lower than in our cohort, although the numbers
are too small to draw any conclusions.
Myocarditis is an inﬂammatory process, not sus-
pected to be of familial origin. Thus, genetic analyses
are not considered in myocarditis. We postulate that a
genetic variation in structural proteins create a
vulnerable myocardium prone to myocardial seeding
by a pathogen. In a prospective investigation, we
collected 3 cases with a diagnosis of death from
myocarditis and identiﬁed PPGV in desmosomal
genes. None of the index cases was suspected of
having arrhythmogenic right ventricular cardiomy-
opathy at autopsy.
The history of events suggests that the genetic
alteration in the desmosome has created the envi-
ronment for the seeding of an infectious agent. Sub-
sequently, it will cascade into an inﬂammatory
process. These data suggest that myocarditis could be
genetically predisposed; thus, family members need
to be investigated clinically and genetically for
structural abnormalities. This proof-of-concept work
reinforces the need for further genetic investigation
of larger cohorts with myocarditis.Oscar Campuzano, PhD
Anna Fernández-Falgueras, MSc
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Pedigree: arrows indicate index case; slashes indicate deceased members; gray indicates structural heart alterations; plus/minus indicates carrier/noncarrier; and
question marks indicate no genetic analysis. Family 1: inﬂammatory inﬁltrates (hematoxylin-eosin, left 4, central 10 epicardium, right 10 myocardium). Family 2:
inﬂammatory inﬁltrates (left 20, hematoxylin-eosin, and right 20, CD45). Family 3: inﬂammatory inﬁltrates (hematoxylin-eosin labeling, left 10, right 20).
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Substrate for
Biventricular PacingIt is axiomatic that the presence of a substrate that
is amenable to a speciﬁc treatment, coupled with
effective delivery of that treatment, is likely to pro-
duce the most favorable clinical outcomes. In patients
with heart failure, left bundle branch block (LBBB)
and the associated abnormal electro-mechanical
activation represents the substrate for biventricular
